TubeRank
LCIDBullmiss
Lucid CityLucid City

Target Price

$14

Looks like the bulls are feeling between 1350 and 14 is on the table.@ 5:42 · open at this moment on YouTube ↗

Thesis at the time

Mixed

A weekend preview video covering the upcoming week. Positive: Lucid plans to expand to ~20 European cities by end-2026, primarily in Germany. Mark's fireside chat claim of 1,000+ vehicles/week in production makes the 18k target logically achievable. Options bulls see $13.50-14 for the week. Negative: Short interest at 33.15% (43.2M shares) is near all-time highs, technicals are poor (below 10-day moving average), and key data points (ADP, non-farm payroll, CPI) could create volatility.

Key arguments

  • Euro expansion to 20 cities by end-2026 (12 in Germany) is a meaningful new catalyst
  • Mark's claim of 1,000+ weekly production makes 18k target logically achievable
  • Short interest at 33.15% (43.2M shares) heading toward all-time highs
  • Options bulls see $13.50-14 range; this week's outlook is cautiously bullish
  • Stochastic RSI at ~74 — not overbought, some room to move higher
  • Strong 2026 guidance (35-40k) needed alongside 2025 target to demoralize shorts

Counter-arguments acknowledged

  • Q4 deliveries historically lag Q4 production at Lucid — market may discount target hit
  • Heavy macro data week (CPI, non-farm payroll) could suppress broader market

The call

Date said
Dec 14, 2025
Deadline
Dec 20, 2025
Price at prediction
$11.81
Confidence
medium
Specificity
specific

How it resolved

Status
miss
Resolution price
$11.82
Return
+0.1%
Notes
Deadline passed. Only 0% progress toward target $14. Price: $11.82.
Why this resolved this way(resolution audit)
Reference price
$11.81 (anchored at quote date)
Target used
$14
Deadline source
Explicit (extracted from quote)
Effective: Dec 20, 2025
Age at resolution
0.2 months(from publish date)
Resolution snapshot
$11.82 on Dec 20, 2025

Rule that fired

Deadline passed. Only 0% progress toward target $14. Price: $11.82.

Full rules: docs/resolution-spec.md.